Overview


Fungi are everywhere in the world and can be found in every environment. Most fungi are harmless and don't cause any disease. However, certain species can infect people and cause illness. Antifungal medications are drugs that are used to treat fungal infections. Although most fungal infections are limited to the skin and nails of the body, some can cause more serious and potentially deadly conditions such as pneumonia and meningitis. Topical antifungal medicine is a treatment that uses a cream or solution to treat fungal infections. It can be a lotion, cream, powder, gel spray, lacquer, spray, or powder applied directly to the skin. Many antifungal medications are compatible with both yeast and dermatophyte infections. Others may be more specific for one type or another of fungus. Because of the growing popularity of topical medication worldwide, the top antifungal drug market share is held by topical. The antifungal drug market is experiencing significant growth because of rising numbers of fungal and nosocomial infections. Antifungal agents can be used to treat systemic or superficial infections caused by exposure to damp conditions in hospitals and other contaminated areas. A significant influence on the growth of the antifungal drug market is the increasing healthcare expenditure, which helps to improve its infrastructure. Additionally, dermatological fungal infections are being treated with topical medication by more medical professionals. This is positively impacting the market growth. Due to the rising demand for topical medicines, key players have begun to concentrate on the production of large quantities of top-quality topical drugs. The growth of the global antifungal market is primarily driven by an increase in fungal and nosocomial diseases. It is also expected that the market for antifungal drugs will expand due to increased awareness by the public and private agencies. In addition, the market growth is driven by the rise in the prevalence of fungal diseases like aspergillosis or candidiasis. Fungal infections are both systemic and superficial. These include infections of the skin and eyes as well as the mouth. The majority of antifungal drugs have fungicidal action and are used to treat a wide range of diseases including fungal meningitis, ringworm, and fungal-caused ringworm. Antifungal drugs are seeing a rise in the number of people with nosocomial diseases and other infectious diseases. In addition, the market's expansion is driven by an increase in research-and-development activities. This will offer opportunities for market growth in antifungal drugs. This will be accompanied by rising drug approvals, and launch rates that will propel the market's growth. Market players are putting more emphasis on generic products that treat fungal infections. This will help boost the market's growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Antifungal Topical Drugs Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Antifungal Topical Drugs Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Abbott laboratories
• Astellas Pharma Inc
• Cardinal Health
• Cipla Ltd
• Connote Healthcare
• Cospex Pharma Pvt Ltd
• Hoffmann-La Roche Ltd
• Hologic Inc
• Sun Pharmaceutical Industries ltd
• Estrellas Life Sciences private Limited
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Drug Class
• Azoles
• Polyenes
• Allylamine
• Others
By Therapeutic Indications
• Aspergillosis
• Dermatophytosis
• Candidiasis
• Others
By Distribution Channel
• Hospital Pharmacies
• Online Providers
• Drug Stores and retail Pharmacies
By Region
• North America
Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Antifungal Topical Drugs Market By Drug Class, By Therapeutic Indications, By Distribution Channel and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antifungal Topical Drugs Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antifungal Topical Drugs Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antifungal Topical Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antifungal Topical Drugs Market, By Drug Class Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Azoles
        2. Polyenes
        3. Allylamine
        4. Others
  • 8.   Antifungal Topical Drugs Market, By Therapeutic Indications Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Aspergillosis
        2. Dermatophytosis
        3. Candidiasis
        4. Others
  • 9.   Antifungal Topical Drugs Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospital Pharmacies
        2. Online Providers
        3. Drug Stores and retail Pharmacies
  • 10.   North America Antifungal Topical Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 11.   Latin America Antifungal Topical Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 12.   Europe Antifungal Topical Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 13.   Asia Pacific Antifungal Topical Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 14.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Astellas Pharma Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cardinal Health
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cipla Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Connote Healthcare
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cospex Pharma Pvt Ltd
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Hoffmann-La Roche Ltd
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hologic Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sun Pharmaceutical Industries ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Estrellas Life Sciences private Limited
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
           10.5. Strategic Overview..
  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients